AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016
Jun 9, 2016
30583_dirs_2016-06-08_fb3e867c-c66c-4dcf-9841-11ede301ad8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-06-06
Reporting Person: HERON ELAINE J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-06 | Common Stock | A | 1510 | — | Acquired | 37135 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-06 | Stock Option (right to buy) Common Stock | $89.52 | A | 4440 | Acquired | 2026-06-05 | Common Stock (4440) | Direct |
Footnotes
F1: Restricted stock units granted on June 6, 2016. Price not applicable.
F2: Option grant vests in full on June 6, 2017.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19